1. Journal searcher
  2. Top 15 journals in Hematology
  3. The Lancet Haematology
Default: The Lancet Haematology

ISSN:

Journal Home

Journal Guideline

The Lancet Haematology Q1 Unclaimed

Lancet Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The Lancet Haematology is a journal indexed in SJR in Hematology with an H index of 93. It has an SJR impact factor of 3,923 and it has a best quartile of Q1. It has an SJR impact factor of 3,923.

The Lancet Haematology focuses its scope in these topics and keywords: duration, elastic, therapy, rituximab, prevention, postthrombotic, compression, treatment, syndrome, standard, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

WOS
Categories: Hematology (Q1)
Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

The Lancet Haematology

3,923

SJR Impact factor

93

H Index

195

Total Docs (Last Year)

598

Total Docs (3 years)

3178

Total Refs

3333

Total Cites (3 years)

291

Citable Docs (3 years)

4.89

Cites/Doc (2 years)

16.3

Ref/Doc

Comments

No comments ... Be the first to comment!
User post comment
* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Hematology and Oncology Q1
Blood Q1
Blood Cancer Journal Q1
Leukemia Q1
Blood advances Q1
Compare this journals

Aims and Scope

duration, elastic, therapy, rituximab, prevention, postthrombotic, compression, treatment, syndrome, standard, lymphoma, cohort, costeffectiveness, shortened, oral, outcome, intravenous, interim, combined, direct, era, european, failure, firstline, follicular, hodgkins, immunotherapy,

FAQS

What is the impact factor of The Lancet Haematology?

In Country of Paypers you can find Impact factor and other metrics to help you decide on a Journal.